Metabolic Syndrome, Inflammation, and Risk of Cognitive Decline

Completed

Conditions studied: Cognitive Decline

In brief

The purpose of this study is to determine if the metabolic syndrome is a risk factor for cognitive decline and if this association is modified by inflammation.

Key facts

Study ID

NCT00099567

Run by

National Institute on Aging (NIA)

People needed

2632

Starts

1997-01-01

Expected to finish

2002-12-01

Last updated by the study team

2005-11-01

Who can join

Age: 70 and older, up to 79. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Aged 70 to 79
• White or Black
• Community-dwelling in Memphis, TN or Pittsburgh, PA vicinity
• Well-functioning (no difficulty in walking a quarter of a mile or going up 10 steps without resting)

You may not qualify if…

• Any difficulty with activities of daily living
• Clinical dementia
• Inability to communicate with interviewer
• Intention of moving out of vicinity in the next year
• Active treatment for cancer in the previous 3 years
• Participation in a trial involving a lifestyle intervention

Where it is running

• Study site — Pittsburgh, Pennsylvania, United States
• Study site — Memphis, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.